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CHAPTER 1: INTRODUCTION
Cardiovascular adaptations during exercise are dependent on the effects of three
major neural control mechanisms. The first is central command, which is associated with
alterations in parasympathetic activity and minimally impacts sympathetic activity (62,
175, 178, 184). The second is the arterial baroreflex which is responsible for autonomic
control of heart rate, and systemic vascular resistance for the maintenance of blood
pressure (4, 31, 37, 60, 73, 77, 82, 87, 93, 107, 116, 119, 149, 152). The last is known
as the exercise pressor response which is due to activation of skeletal muscle afferents.
These afferents can be generally subdivided into mechanosensitive type III afferents, and
metabosensitive type IV afferents, which together culminate in robust increases mean
arterial pressure driven by increased cardiac output via enhanced ventricular function,
tachycardia, and central blood volume mobilization (19, 58, 69, 70, 80, 100, 115, 120,
121, 127, 131, 145, 163) in combination with peripheral vasoconstriction. The relative
roles of cardiac output vs. the peripheral vasculature varies with workload as well as
patho-physiological state.
A profound modulator of central and peripheral cardiovascular function during
exercise is activation of metabolite-sensitive skeletal muscle afferents caused mismatch
between oxygen demand and oxygen delivery (5, 47, 49, 143, 150, 153). Ischemia results
in an enhanced metabolite load that leads to the activation of multiple receptors located
on type III polymodal and type IV skeletal muscle afferents (2, 91, 92, 117, 142, 159, 160,
162, 165, 169). These afferents in turn elicit a sympathetic mediated response causing
increased ventricular function, tachycardia, peripheral vasoconstriction and enhanced
central blood volume mobilization to increase cardiac output and mean arterial pressure
and thereby increase active skeletal muscle perfusion (13, 19, 24, 42, 43, 45, 49, 115,
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127, 128, 131, 140, 145, 151, 153). Although the muscle metaboreflex does enhance
ventricular performance coronary vasoconstriction occurs that functionally limits these
increases (14, 40). In addition to the stifling of ventricular performance there is also
opposition to reflex induced vasoconstriction via adrenal release of epinephrine and
subsequent
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mediated vasodilation within the active skeletal muscle from which the

reflex originates (94).
In heart failure, ventricular function is compromised and the mechanisms by which
muscle metaboreflex activation increases mean arterial pressure are altered (64, 65, 78).
The traditional mechanisms of increasing cardiac output is stifled by reductions in
ventricular contractility brought on by the pathology of heart failure and enhanced
coronary vasoconstriction (13, 41, 129, 144). This in turn shifts the reflex to raise mean
arterial pressure by inducing profound systemic vasoconstriction that even effects the
active skeletal muscle from which the reflex originates (13, 64, 95, 98, 99). Thus, a
positive feedback loop can arise in which enhanced vasoconstriction leads to further
limitations in skeletal muscle perfusion that then further exaggerates the sympathetic
activity of the muscle metaboreflex.
Inasmuch as changes in ventricular and vascular performance during muscle
metaboreflex activation have been observed before and during heart failure, no study has
yet assessed the efficiency of the interaction between the left ventricle and the systemic
vasculature; termed ventricular-vascular coupling with regard to muscle metaboreflex
activation. This interaction is assessed by the ratio of effective arterial elastance to
ventricular maximal elastance (32-34, 39, 54, 57, 89, 102). Effective arterial elastance is
an index of vascular load that integrates vascular impedance and conductance, systolic
and diastolic time decay, and resistance (16, 17, 29, 33, 34, 57, 97, 110, 111, 113, 133,
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134, 138, 139, 171). The muscle metaboreflex in healthy subjects has been shown to
produce vasodilation and vasoconstriction dependent on the vascular bed and both
impact aspects of effective arterial elastance. Ventricular maximal elastance is an
assessment of how well the left ventricle contracts. Muscle metaboreflex activation
enhances ventricular maximal elastance and these increases are severely attenuated in
heart failure (13, 41, 144). Whether or not effective arterial elastance in healthy or heart
failure subjects matches the changes in ventricular elastance to maintain ventricularvascular coupling and optimal energy transfer and thereby increase stroke work during
muscle metaboreflex activation is unknown.
Ventricular contractile dynamics during muscle metaboreflex activation have been
evaluated extensively showing that ventricular maximal elastance, pre-load recruitable
stroke work, and dP/dt

MAX

are all increased (13, 14, 40, 41, 127, 144, 145). However,

assessment of relaxation dynamics and their relationship to contractile dynamics has only
been evaluated in vitro. In vitro studies have shown in multiple genetic models of
cardiovascular disease that the ratio of force generation per unit time (dF/dt MAX and MIN)
of the left ventricle sarcomeres varies minimally regardless of changes in frequency of
contraction, length of muscle stretch, and

adrenergic stimulation (85, 86). No study has

evaluated if these effects are maintained in a whole organ in vivo
The

muscle

metaboreflex

is

elicited

by

metabolites

interacting

with

metabosensitive afferents. Multiple receptors exist on metabosensitive afferents such as
purinergic (P2X), acid sensing ion channels (ASICs),

opioid receptors ( ), and transient

receptor potential vanilloid 1 cation channels (TRPV1) (2, 6-10, 20, 56, 59, 66, 70, 75, 91,
92, 136, 142, 156, 161, 169, 176, 177, 179, 181). Multiple studies have investigated short
term treatments aimed to attenuate signaling through these receptors and thus attenuate
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pressor responses during exercise in various cardiovascular pathologies and alleviate the
sensation of fatigue (8-10, 20, 136, 169, 177, 181). However, these treatments are
dependent on systemically administered therapeutic compounds that may have off target
effects. Thus, the need for a selective long-term method of attenuation of metabosensitive
afferents is needed. TRPV1 channels are activated by changes in H+ concentration but
are also capsaicin sensitive. Resiniferatoxin (RTX) is an ultra-potent dominant negative
agonist of TRPV1 channels that achieve chronic ablation through calcium cytotoxicity that
has been used to attenuate metabosensitive cardiac sympathetic afferents in heart
failure, as well as the relief of nociceptive pain (1, 26-28, 46, 61, 108, 146, 162, 173, 181).
Whether or not administration of intrathecal RTX is capable of effectively attenuating
metabosensitive afferents responsible for the muscle metaboreflex has yet to be
determined. If RTX can effectively attenuate muscle metaboreflex responses in healthy
subjects it poses a potential therapy to alleviate over sympatho-excitation during exercise
in heart failure.
These studies investigate muscle metaboreflex control of ventricular-vascular
coupling, ventricular dynamics, and whether these responses can be attenuated via
chronic ablation of skeletal muscle afferents.

These studies utilized a chronically

instrumented canine model in which each animal serves as its own control in a
longitudinal design.
SPECIFIC AIM 1: Evaluating the effect of muscle metaboreflex activation on
effective arterial elastance and ventricular-vascular coupling before and after
induction of heart failure.
I hypothesize that muscle metaboreflex activation will increase effective arterial
elastance to match ventricular maximal elastance, maintaining ventricular-vascular
coupling, such that optimal energy transfer from the left ventricle to the systemic
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circulation is maintained. In heart failure, metaboreflex-induced increases in arterial
elastance are increased and with impaired ability to raise ventricular elastance the
ventricular-vascular relationship becomes further uncoupled and thus worsens the
already sub optimal energy transfer in heart failure.
SPECIFIC AIM 2: Assessment of ventricular contraction and relaxation dynamics
during muscle metaboreflex activation before and after induction of heart failure.
I hypothesize that muscle metaboreflex activation will alter the ventricular
contraction-relaxation ratio such that relaxation and contraction will become coupled at
similar rates. Heart failure will attenuate increases in relaxation and contraction such that
minimal changes will occur across all workloads. Furthermore, similar to previous
observation on the impact of coronary vasoconstriction in heart failure on ventricular
contractility, I hypothesize heart failure will significantly attenuate relaxation function such
that it becomes a likely contributor to reductions in the ability to raise cardiac output.
SPECIFIC AIM 3: Evaluate the efficacy of chronic ablation of metabosensitive
skeletal muscle afferents during muscle metaboreflex activation using intrathecal
RTX
I hypothesize that intrathecal RTX will significantly attenuate muscle metaboreflex
responses. The effects of RTX will last weeks thereby indicating a possible mechanism
to reduce exaggerated sympathetic activity during exercise in heart failure.
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CHAPTER 2: MUSCLE METABOREFLEX-INDUCED INCREASES IN EFFECTIVE
ARTERIAL ELASTANCE: EFFECT OF HEART FAILURE
(This Chapter contains previously published material. See Appendix B.)
ABSTRACT
Dynamic exercise elicits robust increases in sympathetic activity in part due to
muscle metaboreflex activation (MMA) – a pressor response triggered by activation of
skeletal muscle afferents. MMA during dynamic exercise increases arterial pressure by
increasing cardiac output via increases in heart rate, ventricular contractility, and central
blood volume mobilization. In heart failure ventricular function is compromised and MMA
elicits peripheral vasoconstriction. Ventricular-vascular coupling reflects the efficiency of
energy transfer from the left ventricle to the systemic circulation and is calculated as the
ratio of effective arterial elastance (Ea) to left ventricular maximal elastance (Emax). The
effect of MMA on Ea in normal subjects is unknown. Furthermore, whether muscle
metaboreflex control of Ea is altered in heart failure has not been investigated. We utilized
two previously published methods of evaluating Ea: (end systolic pressure

stroke

volume (EaPV)) and (heart rate x vascular resistance (EaZ)) during rest, mild treadmill
exercise and MMA (induced via partial reductions in hindlimb blood flow imposed during
exercise) in chronically instrumented conscious canines before and after induction of
heart failure via rapid ventricular pacing. In healthy animals MMA elicits significant
increases in effective arterial elastance and stroke work that likely maintains ventricularvascular coupling. In heart failure Ea is high and MMA-induced increases are exaggerated
which further exacerbates the already uncoupled ventricular-vascular relationship which
likely contributes to the impaired ability to raise stroke work and cardiac output during
exercise in heart failure.
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INTRODUCTION
During exercise, the ability to maintain adequate systemic perfusion is dependent
on optimal ventricular-vascular coupling (89, 90, 101). This relationship is an index of the
efficiency to transfer energy from the left ventricle to the arterial circulation, and is
calculated as the ratio of left-ventricular end-systolic elastance (EES) and effective arterial
elastance (Ea) (29, 97, 111, 112, 148, 168, 170-172). Ea can be assessed by end-systolic
pressure divided by stroke volume, as well as heart rate times systemic vascular
resistance (29, 35, 97, 133, 171), and both of these relationships have been used as
minimally invasive measures of Ea in humans (11, 21, 32-34, 36, 57, 97, 125, 139). Ea is
an index of ventricular afterload and integrates the effects of pressure, resistance,
impedance, and cardiac cycle time decay (36, 97, 170, 172). EES accounts for changes
in end-systolic volume and end-systolic pressure, and thereby integrates left-ventricular
dynamics into the ventricular-vascular coupling ratio in a manner relatable to the effects
on ventricular afterload (21, 22, 29, 36, 97, 102, 111, 139, 170). Both Ea and EES can be
altered by a variety of physiological and pharmacological interventions which affect
ventricular performance and vasomotor tone which thereby will alter the ventricularvascular the coupling ratio which, under optimal conditions, ranges between 0.6 and 1.2
in humans (3, 22, 71, 111). Recently, Ea has been used as a diagnostic assessment
measure of ventricular-vascular coupling and ventricular afterload (16, 33, 34, 88, 133,
138). In healthy individuals and canines, Ea increases in response to exercise in parallel
with the rise in ventricular performance which maintains an optimal stroke work (34, 125,
133, 134). In pathophysiological conditions such as heart failure, Ea increases whereas
EES decreases, and ventricular-vascular coupling is reduced which compromises the
ability to maintain or increase stroke work (102, 110, 111, 147).
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When oxygen demand in skeletal muscle exceeds oxygen delivery, metabolites
accumulate in the muscle interstitium and stimulate group III and IV afferents which elicit
activation of a powerful pressor reflex termed the muscle metaboreflex. Activation of this
reflex in healthy individuals during submaximal dynamic exercise induces a pressor
response predominantly caused by increases in cardiac output which occurs via
increases in heart rate, ventricular contractility and central blood volume mobilization (2,
12, 21-23, 26, 31, 34, 48, 58-60, 62, 68-71, 77). Little net change in systemic vascular
conductance is observed as sympathetically-driven vasoconstriction is offset by
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mediated vasodilation in response to epinephrine release (6, 8, 19, 36, 38, 40, 51, 58).
The rise in total systemic blood flow partially corrects the mismatch between O2 delivery
and O2 demand which likely acts to maintain performance for a given workload (11, 24,
25, 49, 55, 64). As workload rises above relatively mild levels, skeletal muscle afferents
become active, and once workloads reach moderate levels, the muscle metaboreflex is
likely tonically active (6, 7, 47, 65, 185).
Muscle metaboreflex activation can elicit marked increases in left-ventricular
maximal elastance (40, 145). In heart failure, the muscle metaboreflex can be over active
due to poor skeletal muscle perfusion and can induce profound peripheral
vasoconstriction (44, 65, 94, 95) which may increase Ea. Increased Ea, coupled with the
inability to raise ventricular performance in heart failure (40, 144), could lead to
ventricular-vascular uncoupling which could further reduce the capacity to raise stroke
work. To what extent MMA influences arterial elastance and affects ventricular-vascular
coupling in normal subjects is unknown. Furthermore, how these relationships are altered
in subjects with marked systolic dysfunction has not been investigated. We hypothesized
that, in normal subjects, MMA will increase Ea in parallel with increases in EES thereby
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maintaining optimal ventricular-vascular coupling and stroke work. However, in heart
failure, metaboreflex-induced increases in Ea, without concomitant increases in
ventricular function, will result in ventricular-vascular uncoupling and reduced stroke work.
METHODS
Experimental Subjects
Five adult mongrel canines (1 male, 4 females) of approximately 19-25 kg were
selected based on willingness to walk on a motor-driven treadmill and then acclimatized
to a workload of 3.2 km/hr with 0% incline. We have shown that gender does not affect
the strength or mechanisms of the muscle metaboreflex in normal canines (104). No
experiments were performed during the estrus phase. All experimental and surgical
procedures utilized for this study comply with the National Institutes of Health Guide to
the Care and Use of Laboratory Animals and were approved by the Wayne State
University Institutional Animal Care and Use Committee (IACUC). Animals utilized in this
study underwent a seven-day acclimation period with laboratory surroundings and
personnel and exercised on their own volition during all experiments.
Surgical Instrumentation
All animals were instrumented in a series of surgical procedures spanning over a
period of at least six weeks using standard aseptic techniques. Prior to each surgery,
animals were sedated with an intramuscular injection acepromazine (0.4-0.5 mg/kg) 30
minutes prior to induction of anesthesia with intravenous administration of ketamine (5
mg/kg) and diazepam (0.2-0.3 mg/kg). Anesthesia was then maintained pre-operatively
and during surgery with (1-3%) isoflurane gas. Preoperative analgesics included
[Fentanyl 75-125 g/h (72) transdermal delivery] buprenorphine (0.01-0.03 mg/kg IM) and
carprofen (4.4 mg/kg IV). Postoperatively acepromazine (0.2-0.3 mg/kg IV) and
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buprenorphine (0.01-0.03) were administered. Acute proactive antibiotics (cephalexin 30
mg/kg IV) were administered pre- and post-operatively, and prophylactic antibiotics
(cephalexin 30 mg/kg PO BID) were administered to prevent microbial infection.
The first surgical procedure performed was a left thoracotomy exposing the heart
through the 3rd/4th intercostal space. The pericardium was incised to allow placement of
a telemetric pressure transducer tip (TA11 PA-D70, DSI) into the apex of the left ventricle
with the implant body tethered subcutaneously. The upper section of dissected
pericardium was then retracted for placement of a blood flow transducer (20PAU,
Transonic Systems) around the ascending aortic trunk to measure cardiac output. Four
stainless steel pacing leads (0-FLexon, Ethicon) were attached to the right ventricle free
wall for subsequent induction of heart failure via rapid ventricular pacing. For studies
unrelated to these observations, a blood flow probe (3PSB, Transonic Systems) was
placed on the circumflex artery. All leads and wires were tunneled subcutaneously and
exteriorized between the scapulae. The pericardium and ribs were reapproximated and
the chest was closed in layers.
The second procedure occurred no earlier than two weeks post-thoracotomy.
Through a left retroperitoneal approach, all arterial blood vessels caudal to the renal
artery and cranial to incision point near the iliac crest were ligated. To measure systemic
arterial pressure, a 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was inserted
into the most accessible cranial ligated branch of the terminal aorta. In order, cranial to
caudal, a 10 PAU blood flow transducer (Transonic Systems) and two 8-10mm hydraulic
occluders (DocXS Biomedical Products) were placed caudal to the systemic arterial
pressure catheter to measure and manipulate terminal aortic blood flow. Cables,
catheters and occluder lines were then tunneled subcutaneously and exteriorized
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between the scapulae. A 4PSB flow probe (Transonic Systems) was placed on the left
renal artery and, when accessible, a second 19-gauge polyvinyl catheter (Tygon, S54HL, Norton) was placed in the inferior mesenteric artery (N=2) for purposes unrelated to
this study. In the event the mesenteric artery was inaccessible during a separate
procedure, no earlier than two weeks after recovery, a 19-gauge polyvinyl catheter
(Tygon, S54-HL, Norton) was placed in the femoral artery branch through a vertical
incision in the right hindlimb. Cables and catheters were exteriorized subcutaneously from
their point of origin to the scapulae. The retroperitoneal space was then closed in
successive layers.
A third procedure, unrelated to this study, was performed after a two-week
recovery period. Via a midline incision in the neck both carotid arteries were accessed
and one 4-6 mm hydraulic occluder (DocXS Biomedical Products) was placed on each
side. Occluder lines were tunneled subcutaneously to the scapulae and exteriorized. The
neck was closed in successive layers and animals recovered for 10-14 days prior to any
experimental procedures.
Data Acquisition
All animals were acclimated in the laboratory 10-20 minutes prior to being led to
the motor-driven treadmill. Arterial pressure was measured through a connection to a
pressure transducer (Transpac IV, ICU Medical). Heart rate and left-ventricular pressure
were derived from a left-ventricular pressure sensor (DSI). All flows were measured by
connecting flow probes to benchtop flowmeters (Transonic Systems). Hemodynamic
variables were monitored and recorded in real time through an A-D converter (iWorx)
output into Labscribe2 acquisition and analysis software (iWorx).
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Experimental Procedures
Hemodynamic parameters were recorded under steady-state conditions of rest,
mild free-flow exercise (3.2 km/h 0% grade), and during sustained exercise with
successive reductions in hindlimb blood flow (via partial inflation of the terminal aortic
hydraulic occluders to 50-60% of free-flow conditions). After completion of control
experiments, heart failure with reduced ejection fraction was induced via rapid ventricular
pacing as described in previous studies (13, 18, 41, 64, 65, 78, 79, 83, 95, 98, 129, 131,
144). Briefly, the ventricular pacing wires were connected to a pacemaker, and over
several days the rate was increased to ~230 bpm. Rapid ventricular pacing was continued
for ~30 days until clear clinical indices of moderate ventricular dysfunction were observed,
which included tachycardia in the absence of pacing, low cardiac output, low stroke
volume and compromised ventricular contractility shown by dP/dt

MAX

and

MIN.

The

experiments were then repeated as in control. The pacemaker was disconnected ~30
minutes prior to every experiment and then reconnected after the experiment was
completed. Thus, each animal served as its own control for these longitudinally designed
studies.
Analysis
All in vivo hemodynamics (mean arterial pressure, heart rate, cardiac output, leftventricular pressure, hindlimb blood flow) were continuously recorded for each
experiment. Steady state values at rest, during mild exercise, and with MMA were
averaged over minute. All other hemodynamic variables were derived mathematically
from in vivo measurements. For measures of Ea, we utilized two equations initially
developed by Kelly et al. (97), one of which has been modified to account for the hydraulic
effects of vascular occluder inflation used to activate the muscle metaboreflex. Kelly et al.
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(97) denoted the first equation as EaPV and the second as EaZ.
Equation 1:
EaPV = ESP

SV

Equation 2:
EaZ = NIVR x HR
* NIVR = MAP

(CO - HLBF)

- NIVR is non-ischemic vascular resistance and is resistance of all vascular beds
except the ischemic hindlimb
- HLBF is hindlimb blood flow and is sequentially partially reduced to elicit muscle
metaboreflex activation via hindlimb vascular occluders
Since during metaboreflex activation arterial pressure can increase somewhat
simply due to the passive, mechanical effects of the occluder, we adjusted the latter
vascular based equation (EaZ) by using only vascular resistance of all non-ischemic beds
which thereby only accounts for increases in pressure due to reflex activation (140).
For this study, multiple experiments were conducted on each animal and steadystate values taken at rest, exercise, and maximal muscle metaboreflex activation were
averaged across experiments for each individual animal. Averaged steady-state values
for each animal were then averaged across all animals, thus each animal contributed to
the mean values only once.
Statistical Analysis
All statistics were performed with Systat Software (Systat 11.0) and data are
reported as mean

SE and statistical significance was determined by an

level of P <

0.05. The data were analyzed via Two-way ANOVA for Repeated Measures and when a
significant interaction was observed, individual means were compared using C Matrix
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Test for Simple Effects. The effect of heart failure on the changes induced by MMA
(changes from steady state exercise) were compared via Student’s Paired T-Tests.
Additionally, a Bland-Altman plot was constructed to evaluate the agreement between our
two measures of Ea similar to Kelly et al. (97).
RESULTS
Figure 2.1 shows the average hemodynamic parameters during control and after
the induction of heart failure at rest, during mild exercise and during MMA. Figure 2.2
shows

the

resultant

calculated levels of Ea: EaPV
and EaZ and stroke work in
each

setting

changes
between
exercise

and

which

the

occurred

exercise
with

and

MMA.

In

control experiments during
the transition from rest to
exercise

cardiac

output

significantly increases with
no significant change in
mean

arterial

pressure.

During MMA cardiac output
increased which occurred
via

large

significant

increases in heart rate and

Figure 2.1 Average one minute steady state values of cardiac output, mean
arterial pressure, end systolic pressure, stroke volume, non-ischemic vascular
resistance, heart rate, at rest (REST), during free-flow mild exercise (EX), and EX
with muscle metaboreflex activation (EX + MMA) induced by graded reductions in
hindlimb blood flow of 50-60% before (white bars) and after induction of heart
failure (grey bars). Standard error is shown on bar graphs with individual data
points overlaid. Statistical significance compared to the previous setting shown as
* P < 0.05. Comparisons between control and heart failure within each setting
shown as † P < 0.05. (N=5).
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small but significant increases in stroke volume. Mean arterial pressure during MMA
increased significantly due to increased cardiac output with minimal changes in nonischemic

vascular

resistance.

In

control

experiments, neither index
of Ea changed from rest to
mild exercise: EaPV was
unaffected as little change
in

either

end-systolic

pressure or stroke volume
occurred

and

EaZ

was

unaffected as decreases in
resistance were balanced
by increases in heart rate.
In response to MMA, both
indices of Ea increased:
EaPV

increased

due

to

large, significant increases
in
with

end-systolic

pressure

small,

significant

Figure 2.2. A) Average one-minute steady state indices and of effective
arterial elastance derived from traditional pressure volume loop calculation
[(EaPV) end systolic pressure (ESP) divided by stroke volume (SV)] and from
vascular components [(EaZ) heart rate (HR) multiplied by non-ischemic
vascular resistance (NIVR)]. Mean values shown at rest (REST), during freeflow mild exercise (EX), and EX with muscle metaboreflex activation (EX +
MMA) induced by graded reductions in hindlimb blood flow of 50-60% before
(white bars) and after induction of heart failure (grey bars). B) Average
changes between one-minute steady state values during exercise and
exercise with muscle metaboreflex activation. Standard error is shown on bar
graphs and individual data points are plotted. Statistical significance between
successive settings shown as * P < 0.05. Comparisons between control and
heart failure shown as † P < 0.05. (N=5).

increases in stroke volume, and EaZ increased due to large increases in heart rate
offsetting small reductions in resistance. Stroke work was used as an additional index of
ventricular-vascular coupling. Stroke work increased significantly from rest to exercise
and then again from exercise to MMA. Figure 2.3 shows left-ventricular dP/dt as an index
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of the ventricular contribution to the ventricular-vascular coupling relationship. Ventricular
contractility (dP/dtmax) and lusitropy (dP/dtmin), significantly increased from rest to mild
exercise. During MMA, there were large significant increases in ventricular performance.

Figure 2.3. A)Average one-minute steady state indices of ventricular function dP/dtMAX and dP/dtMIN taken from the
first derivative of the left ventricular pressure wave. Mean values shown at rest (REST), during free-flow mild exercise
(EX), and EX with muscle metaboreflex activation (EX + MMA) induced by graded reductions in hindlimb blood flow of
50-60% before (white bars) and after induction of heart failure (grey bars). B) Average changes between one-minute
steady state values during exercise and exercise with muscle metaboreflex activation. Standard error is shown on bar
graphs and individual data points are plotted. Statistical significance between successive settings shown as * P < 0.05.
Comparisons between control and heart failure shown as † P < 0.05. (N=5).

In heart failure, end-systolic pressure and stroke volume were significantly lower
and heart rate was significantly higher when compared to control (Figure 2.1). Significant
reductions in stroke volume with limited significant increases in heart rate in heart failure
lead to significant reductions in cardiac output and mean arterial pressure across all
workloads. In heart failure increases in cardiac output with MMA were attenuated. After
the induction of heart failure, both indices showed that Ea was significantly increased
across all settings vs. control. In heart failure, no significant changes were observed from
rest to exercise in either index of Ea: for EaPV, similar to control experiments, minimal
changes in end-systolic pressure and stroke volume were observed and, again for EaZ,
reductions in resistance were offset by increases in heart rate. In response to MMA in
heart failure, EaPV significantly increased as a result of significant increases in end-systolic
pressure with no significant changes in stroke volume and EaZ significantly increased due
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to large, significant increases in heart rate with minimal changes in nonischemic vascular
resistance. These muscle metaboreflex-induced increases in Ea were enhanced by heart
failure by approximately 35% vs. control. In heart failure, stroke work is significantly
increased from rest to exercise, but did not further increase in response to MMA, likely as
a result of ventricular-vascular uncoupling. Ventricular function is significantly reduced in
heart failure (Figure 2.3). In heart failure, ventricular contractility (dP/dtmax) and lusitropy
(dP/dtmin), significantly increased from rest to mild exercise. Muscle metaboreflex
activation in heart failure elicits significant increases in ventricular contractility compared
to exercise conditions. However, the capacity to increase ventricular function during MMA
is significantly attenuated in heart failure when compared to healthy animals.
Figure 2.4 illustrates a Bland-Altman plot constructed to assess the effects of bias

Difference EaPV – EaZ
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Mean EaPV and EaZ
Figure 2.4 Bland Altman plot evaluating the agreement between EaPV and EaZ before (filled) and after induction of
heart failure (open) during rest (squares), free flow exercise (triangles), and exercise with peak muscle metaboreflex
activation (circles). Dash lines indicate upper and lower limits of agreement, and the solid line indicates bias. (N=5).
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and agreement between our measures of Ea (EaPV and EaZ) in the 5 animals before and
after the induction of heart failure. This plot was constructed by taking the averages of
EaPV and EaZ from each animal during each steady state as a means to remove any single
animal’s bias in the analysis that may impact the 95% confidence interval. For
comparisons of measurements, we utilized all collected Ea measures across each
workload before and after induction of heart failure and found that the bias between the
two measures was only 0.1 and all data points fall within the limits of agreement.
DISCUSSION
This is the first study to demonstrate that muscle metaboreflex activation increases
Ea. Furthermore, we showed that muscle metaboreflex-induced increases in Ea are
exaggerated after induction of heart failure. In control experiments, metaboreflex-induced
increases in Ea occur in parallel with increases in ventricular performance as shown by
increases in dP/dt MAX and MIN (13, 40, 41, 144, 145), which thereby serves to sustain the
ability to increase stroke work via efficient energy transfer from the left ventricle to the
systemic circulation. In contrast, after induction of heart failure, ventricular performance
is compromised (40, 41, 144, 145) and Ea is significantly elevated even at rest. In this
setting MMA elicits substantial further increases in Ea, yet without concomitant increases
in ventricular function, the ventricular – vascular interaction becomes further uncoupled
which likely contributes to the impaired ability to raise stroke work and cardiac output.
Arterial Elastance
Ea has been used to estimate the arterial load imposed on ventricular function to
gain insight into the regulation of systemic blood flow in normal subjects and in patients
with declining ventricular function and increased vascular stiffing with aging and disease
(11, 33-35, 57, 97, 103, 125, 138, 139, 148).
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Ea was first utilized to estimate stroke volume from vascular parameters and
ventricular pressure, but later evolved as a methodology to assess ventricular efficiency
as it relates to stroke work (29, 171). Optimal stroke work reflects efficient ventricularvascular coupling and ensures that for a given cardiac cycle, blood flow mechanics are
maintained, thereby preserving adequate systemic blood flow. When the ventricularvascular relationship becomes uncoupled, the ability of the heart to perform work is
impaired. Thus, changes in stroke work indirectly assess changes in ventricular-vascular
coupling. We observed that MMA during submaximal dynamic exercise evokes significant
increases in Ea as well as stroke work, suggesting that optimal ventricular energetics are
maintained. However, after induction of heart failure, Ea is significantly increased and
stroke work is significantly reduced, indicating ventricular-vascular uncoupling. With MMA
there are further increases in Ea and significant decreases in stroke work. We have
previously shown that during MMA in animals after the induction of heart failure there is
no increase in EES (13, 40, 144). Thus, with our present findings demonstrating that Ea
rises from an already elevated level and our previous findings that EES does not change
from an already depressed level, we conclude that during MMA in heart failure the already
compromised ventricular-vascular relationship becomes even more uncoupled. This
likely contributes to the impaired stroke work and cardiac output. With diminished ability
to raise cardiac output, the ability of the muscle metaboreflex to raise blood flow to active
skeletal muscle is reduced which likely contributes to exercise intolerance and enhanced
sympatho-activation observed in heart failure (13, 41, 64, 65, 78, 95, 129, 131, 144).
Maintenance of ventricular-vascular coupling is paramount to cardiovascular
efficiency. Instances of altered ventricular-vascular coupling have been observed in a
myriad of conditions in which cardiovascular performance is altered or reduced (32, 33,
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53, 57, 102, 125, 134). During exercise in healthy subjects, exercise performance is highly
dependent on the efficiency of the cardiovascular system to maintain adequate perfusion
of active tissues. Traditionally, during submaximal dynamic exercise, the muscle
metaboreflex has been considered as a heart-centric reflex that drives the pressor
response through increased cardiac output achieved via tachycardia, enhanced
ventricular performance, and increased central blood volume mobilization (131, 145). If
the ventricular component of ventricular-vascular coupling is not matched by similar
changes in arterial properties, ventricular-vascular efficiency would be depressed which
could negatively impact systemic blood flow and perfusion pressure. Conversely, if
arterial properties were to greatly exceed the contribution of ventricular function, such as
with enhanced sympatho-excitation in heart failure and hypertension (64, 95, 166), then
energy generated by the heart would be stifled by the increased afterload which could
thereby limit perfusion during exercise.
The impact of vascular modulation plays a key role in determining the impact of Ea
on ventricular-vascular dynamics. We previously observed that MMA can modulate
vascular resistance thru

2-mediated

dilation, vasoconstriction of ischemic skeletal

muscle and coronary vascular beds, as well as shifts in reflex characteristics during highintensity workloads and pathophysiological states (19, 40, 65, 94-96, 140, 166).
Furthermore, the baroreflex modulates vascular tone and has been proposed as a buffer
to muscle metaboreflex control of vascular function (13, 79, 98-100). To what extent the
arterial baroreflex and other vascular-centric sympatho-excitatory stimuli may assist or
oppose optimal ventricular-vascular coupling during MMA is unknown.
Methodological Considerations
Our two methods to assess Ea are adaptations of previous derivations and agree
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with very small bias as shown by the Bland-Altman plot (Figure 4) (97). We modified one
of the methods to calculate Ea to take into account the passive hydraulic effects of the
vascular occluder used to activate the muscle metaboreflex. We feel the small observed
bias occurs in part due to the location of the arterial pressure catheter. This catheter is
located downstream within the aorta at a point in which we feel the impact of systemic
impedance and resistance are more influential on the calculation of EaZ. Inasmuch as the
ventricle is also subject to these factors, we believe variability in the lumped effect of
impedance and resistance at the aortic valve are reduced as this point is the culmination
of wave reflection, resistance and impedance. We used NIVR in place of TPR to eliminate
the effects of the vascular occluder on measured resistance and this substantially
reduced the bias between the two indices of Ea. Inflation of the vascular occluder also
raises pressure due to the passive hydraulic effect (19). We can subtract the difference
between observed mean arterial pressure and the calculated effect of the rise in mean
arterial pressure due to inflation of the occluder (19, 150) and this in turn normalizes the
difference in the two measures accounting for bias observed across individual conditions
such that the absolute value of the bias calculated a Bland-Altman plot remains the same.
In regard to values near or just above our limits of agreement, we find that applying this
estimate brings them closer to the mean bias and well within the 95% confidence interval.
Therefore, we believe the data presented in this study coincide with Kelly et al. (97), and
that EaPV and EaZ may act as interchangeable measures of Ea for future studies so long
as accommodations are made to account for the impact of the hydraulic effects of the
occluder. Both indices of Ea increased with MMA in parallel with increases in ventricular
contractility (40, 41, 144, 145).
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Muscle Metaboreflex in Heart Failure
Our previous studies have shown that the strength and mechanisms of the muscle
metaboreflex are altered in heart failure (13, 41, 64, 83, 95, 99, 129, 131, 144) which are
supported by subsequent studies in humans (15, 42-45, 50, 58, 59, 67, 76, 77, 122, 141,
154, 155, 158-161). Whether the strength (gain) of this reflex is increased or decreased
is of some debate (10, 19, 23, 41, 44, 51, 78, 95, 99, 114, 117, 118, 120, 121, 129, 131,
154, 157, 163) and our studies support both sides. Much depends on how the reflex
strength is quantified. Clearly, with the impaired ventricular function in heart failure, the
ability of the reflex to raise cardiac output is attenuated (13, 40, 64, 129). However, we
have also shown that metaboreflex induced-peripheral vasoconstriction (64, 65) as well
as constriction of the coronary circulation (41) and even the ischemic active skeletal
muscle from which the reflex arises are enhanced in heart failure (95). Metaboreflexinduced increases in the release of renin and vasopressin are also substantially increased
in heart failure as are the plasma levels of circulating norepinephrine indicating increased
sympatho-activation (65). These latter observations would support an accentuated reflex.
Further complicating the issue is that the metaboreflex is buffered by the arterial
baroreflex (4, 93, 99, 100) which in normal animals reduces the pressor response by ~
50% (152).

The greater metaboreflex-induced pressor response observed after

baroreceptor denervation occurs by substantial peripheral vasoconstriction now
accompanying the rise in cardiac output (98). Thus, the baroreflex buffers the
metaboreflex by preventing metaboreflex-induced peripheral vasoconstriction (98-100).
In heart failure, baroreflex buffering is likely attenuated and baroreceptor denervation
induces little change in the mechanisms of the muscle metaboreflex (98, 99). In heart
failure, the metaboreflex switches from the normal response of increased cardiac output
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and little vasoconstriction

to limited increases in cardiac output and substantial

vasoconstriction (41, 44, 64, 65, 95, 129, 131, 144). After baroreceptor denervation in
heart failure this same pattern remains, but modestly exaggerated (99). These results
would support the hypothesis that in heart failure, depressed baroreflex buffering may
allow greater metaboreflex-induced peripheral vasoconstriction.
During mild exercise, a threshold level of hindlimb blood flow exists before the
metaboreflex is engaged. In heart failure, the normal level of blood flow is lower, but a
clear threshold is still seen during mild exercise. However, at moderate workloads the
threshold of the muscle metaboreflex is much closer to the normal level of blood flow
even in normal animals and minimal if any reduction in hindlimb blood flow is capable of
eliciting, or further activating the muscle metaboreflex (64). Studies in humans also
concluded that skeletal muscle afferents are tonically active and contribute to reflex
cardiovascular responses to dynamic exercise at relatively low workloads (10). In heart
failure, during moderate exercise the level of hindlimb blood flow is already below the
threshold as ascribed in the control experiments prior to heart failure induction and any
further reduction in blood flow causes further increases in sympathetic activity indicating
that the reflex is over-active in heart failure due to impaired skeletal muscle blood flow
(13, 19, 65, 140, 145)
Perspectives and Significance
This is the first study to evaluate muscle metaboreflex control of effective arterial
elastance and thereby ventricular-vascular coupling and stroke work. Our results show
that activation of the muscle metaboreflex increases effective arterial elastance to a
similar extent as we have previously shown for maximal ventricular elastance (144, 145)
which thus maintains ventricular-vascular coupling at optimal levels. Heart failure
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enhances Ea at rest and reduces stroke work and ventricular maximal elastance (144,
145) causing ventricular-vascular uncoupling. With metaboreflex activation substantial
further increases in Ea occur which are not paralleled by increases in maximal ventricular
elastance (144) thereby further uncoupling the ventricular-vascular relationship which
attenuates increases in stroke work, cardiac output and ultimately skeletal muscle
perfusion. Impaired skeletal muscle blood flow during exercise likely over-activates the
muscle metaboreflex contributing to the often profound sympatho-activation (6, 8, 10, 13,
65, 67, 126, 157, 169). Thus, limitations in skeletal muscle perfusion as a result of
inadequate energy transfer from the left ventricle to the system circulation may be the
cause of exaggerated sympathetic activation during exercise in heart failure which may
contribute to exercise intolerance.
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CHAPTER 3: VENTRICULAR CONTRACTION AND RELAXATION RATES DURING
MUSCLE METABOREFLEX ACTIVATION IN HEART FAILURE: ARE THEY
COUPLED?
ABSTRACT
The relationship between contraction and relaxation rates of the left ventricle varies
with exercise and is paramount to the maintenance of cardiovascular performance during
exercise. In in vitro models, this ratio was shown to be relatively unaltered by changes in
sarcomere length, frequency of stimulation and

adrenergic stimulation. In this study we

investigated whether the ratio of contraction to relaxation rate is maintained in the whole
heart during exercise and sympathetic activation elicited by the muscle metaboreflex and
whether heart failure alters these relationships. We observed that in healthy subjects the
ratio of contraction to relaxation increases from rest to exercise as a result of a higher
increase in contraction relative to relaxation. During muscle metaboreflex activation the
ratio of contraction to relaxation is significantly reduced towards 1.0 due to a large
increase in relaxation rate matching contraction rate. After induction of heart failure,
contraction and relaxation rates are significantly reduced and increases during exercise
are attenuated. A significant increase in the ratio was observed from rest to exercise
although baseline ratio values were significantly reduced close to 1.0 when compared to
healthy subjects. There was no significant change observed between exercise and
muscle metaboreflex activation nor was the ratio during muscle metaboreflex activation
significantly different between heart failure and control. We conclude that heart failure
reduces the muscle metaboreflex gain and absolute values of contraction and relaxation
rates. Furthermore, we observed that the ratio of contraction and relaxation rates is not
significantly different, however, significant changes in the ratio in healthy subjects as a
result of increased relaxation rate are abolished in heart failure.
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INTRODUCTION
Ventricular performance is a key determinant of the cardiac response to dynamic
exercise and the maintenance of exercise workload. A key reflex mediating increases in
cardiac output in response to exercise is the muscle metaboreflex - initiated via increases
in activity of skeletal muscle afferents sensitive to increases in metabolite concentration
(2, 13, 40, 42, 43, 45, 64, 91, 92, 96, 121, 123, 127, 128, 131, 142, 151, 158-161). When
activated this reflex causes significant increases in heart rate, stroke volume, ventricular
performance, and central blood volume mobilization which increases cardiac output and
thereby perfusion of the active skeletal muscle (42, 43, 45, 64, 96, 127, 128, 131, 140,
145). After induction of heart failure, the ability of this reflex to raise ventricular
performance and thus cardiac output is attenuated, and the reflex now elicits profound
peripheral vasoconstriction including within the ventricular myocardium and even the
active skeletal muscle, the tissue from which the reflex originates (13, 41, 44, 64, 95, 99,
129, 144, 154, 157). Inasmuch as muscle metaboreflex control of central blood volume
mobilization is maintained in heart failure (131), the mechanism for the reduction in the
ability to raise cardiac output during muscle metaboreflex activation is likely impaired
ventricular dynamics due to both the inherent dysfunction of the myocardium coupled with
enhanced coronary vasoconstriction (13, 40, 41). Previously we have reported that left
ventricular maximal elastance, preload recruitable stroke work, and dP/dt MAX and MIN are
all reduced and exhibit attenuated responses during muscle metaboreflex activation
(MMA) in heart failure (13, 41, 129, 144). Previous in-vitro studies of sarcomere dynamics
determined that the ratio of contraction to relaxation rates are maintained in cardiac
muscle in response to changes in frequency, length, and beta adrenergic stimulation (85,
86). Whether or not aspects of single sarcomere dynamics will be reflected in the whole
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heart in-vivo has yet to be determined. We assessed whether ventricular contraction and
relaxation rates as determined by dP/dt

MAX

and

MIN

in the canine model are coupled

between rest and mild exercise and with pronounced further sympathetic activation
induced by MMA. We also assessed whether heart failure affects these relationships.
Secondly, we wished to determine the strength or gain of the muscle metaboreflex in the
control of ventricular contraction and relaxation rates before and after the induction of
heart failure. We hypothesized that muscle metaboreflex activation before or after heart
failure will not impede contraction-relaxation coupling and heart failure will induce a
significant reduction in the gain (strength) of ventricular contraction and relaxation rates.
METHODS
Experimental subjects. The experiments were performed on 14 adult mongrel
canines (1 male, 13 females) of approximately 18-25 kg were selected on their willingness
to walk on a motor driven treadmill prior to acclimatization to a workload of 3.2 km/h 0%
grade. The gender mix was determined by the availability of animals from the vendor.
Previously we have shown that sex does not significantly impact the strength or
mechanisms of the muscle metaboreflex (104). No experiments during frank estrus were
included in this study. All procedures, surgical and experimental used in this study comply
with the National Institutes of Health Guide to the Care and Use of Laboratory Animals
and were approved by the Wayne State University Institutional Animal Care and Use
Committee (IACUC). All animals in this study underwent a 7-14-day acclimation period to
the laboratory surroundings and personnel prior to volitional treadmill exercise. All
animals exercised voluntarily during all experiments.
Surgical Procedures
Animals underwent a series of surgical procedures spanning 4-6 weeks utilizing
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standard aseptic techniques. All surgical procedures and medications used in this study
have been described previously (13, 40, 41, 93, 95, 96, 115, 144, 145). Briefly the first
procedure was a left thoracotomy thru the 3rd/4th intercostal space to access the heart.
The pericardium was incised cranially to caudally to access the apex of the heart for
insertion of a telemetric pressure transducer tip (TA11 PA-D70, DSI) to measure LV
pressure, and to access the ascending aorta for placement of a blood flow transducer
(20PAU, Transonic Systems) for measures of cardiac output. Four stainless steel pacing
leads (0-Flexon, Ethicon) were attached to the right ventricle free wall for subsequent
induction of heart failure via rapid ventricular pacing. 7 of 14 animals were surgically
prepared with sonometric crystals in the long and short axis of the left ventricle, a blood
flow transducer (3PSB, Transonic Systems) on the circumflex artery as an index of
coronary blood flow, and vascular occluders (DocXS Biomedical Products) were placed
on the superior and inferior vena cava for experimental questions unrelated to the current
study. All cables, wires, and occluder lines were tunneled subcutaneously between the
scapulae and animals recovered for 14 days prior to further experiments or surgical
procedures.
In the second procedure a left retroperitoneal approach was performed to access
the terminal aorta for placement of a 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton)
in a lumbar artery caudal to the left renal artery for measures of systemic arterial pressure.
A blood flow transducer (10PAU Transonic Systems) was placed on the terminal aorta
caudal to the catheter for measures of hindlimb blood flow, followed by two hydraulic
vascular occulders (DocXS Biomedical Products) used to manipulate hindlimb blood flow
during experiments. On the left renal artery, a blood flow transducer (4PSB Transonic
Systems) was placed for studies unrelated to the present investigation. All cables,
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catheters, and occluders were tunneled subcutaneously to the scapula and animals then
recovered for a minimum of 14 days prior to any experiments or additional surgeries.
Six out of fourteen animals in this study underwent a third procedure for placement
of vascular occluders (DocXS Biomedical Products) bilaterally on the carotid arteries for
experimental questions unrelated to the current study. These animals were allowed to
recover for 10-14 days prior to experiments of surgeries. Pre and postoperative care are
described in previous studies (19, 40, 41, 94, 95, 115, 144, 145, 166).
Data Acquisition
Prior to the experiments the animals were acclimated to the laboratory setting for
15-20 minutes. Animals were then led to the motor driven treadmill for connection of
monitoring equipment. Arterial pressure was measured through a direct connection from
the fluid filled 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) to a pressure
transducer (Transpac IV, ICU Medical). The telemetric pressure tip placed in the left
ventricle was connected and left ventricular pressure and heart rate were derived. All flow
probes were connected to bench top flow meters (Transonic Sysytems). All in vivo
hemodynamic measurements were continuously monitored in real time through passage
of signals through an A-D converter (iWorx) and output into Labscribe Acquisition
software (iWorx).
Experimental Procedures
All in-vivo hemodynamics were measured under steady state conditions taken at
rest, exercise (3.2km/h 0% grade), and during exercise. In 7 animals, responses were
observed with successive reductions in hindlimb blood flow to approximately 40-60% of
free flow conditions. Reductions in hindlimb blood flow were achieved through inflation of
vascular occluders (DocXS Biomedical Products). In 7 animals, the muscle metaboreflex
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was activated via a one-step reduction in hindlimb blood flow to values similar to the
maximal occlusion used in the graded reduction protocol. After control experiments were
performed in all 14 animals, the ventricular pacing leads were connected to a pacemaker
for rapid ventricular pacing (200 to 240 bpm, ~ 30 days) to achieve heart failure with
reduced ejection fraction as described in previous studies (13, 41, 64, 95, 115, 129, 131,
144). Heart failure was indicated by frank reduction in ventricular performance was
apparent when the pacemaker was disconnected; e.g., substantial reductions in dP/dt MAX
and

MIN,

tachycardia in the absence of pacing, reduced cardiac output, and hypotension

at rest. After heart failure was induced the experiments were repeated. The pacemaker
was disconnected approximately 30 minutes prior to each experiment and reconnected
afterwards for maintenance of heart failure. Thus, each animal served as its own control
in this longitudinally designed study.
Analysis
In vivo hemodynamics (cardiac output, hindlimb blood flow, renal blood flow, mean
arterial pressure, left ventricular pressure) were measured and recorded continuously for
each experiment. Average one-minute steady state values were taken at rest, exercise
(3.2km/h) 0 % grade), and each successive reduction in hindlimb blood flow during
exercise. Peak reductions in hindlimb blood flow (HLBF) were used to assess peak
muscle metaboreflex activation. All other variables were derived from in-vivo steady state
hemodynamic measures. The gain of the muscle metaboreflex was determined as the
slope of the relationship between the reduction in hindlimb blood flow and the given reflex
response once hindlimb blood flow had been reduced beyond metaboreflex threshold (13,
41, 65, 94, 95, 140, 166, 185). Multiple experiments were conducted on each animal in
this study. Therefore, steady state values for each animal were averaged across all
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experiments from that individual animal. Average values for each animal were then
averaged across all animals such that each animal contributed only once to the mean
values.
Statistical Analysis
All statistics were performed with Systat Software (Systat 13). Data is reported as
standard error of the mean with statistical significance determined by an

level of P <

0.05. A Two-Way ANOVA for repeated measures was used for analysis and when
significant interactions were observed means were compared using a C-Matrix Test for
Simple Effects. Observations of muscle metaboreflex gain and changes observed from
exercise to muscle metaboreflex activation between control and heart failure were
compared using a Students Paired T-Test.
RESULTS
Figure 3.1 shows the average steady-state hemodynamic responses in 14 animals
during rest, exercise (3.2 km/h 0% incline), and exercise with peak muscle metaboreflex
activation before and after induction of heart failure. In normal subjects, significant
increases in heart rate (HR), stroke volume (SV), cardiac output (CO), stroke work (SW,
calculated as (MAP x SV)), and non-ischemic vascular conductance (NIVC) (conductance
to all areas except the hindlimb calculated as (CO-HLBF)/MAP)) were observed from rest
to exercise. With subsequent muscle metaboreflex activation, heart rate, stroke volume,
cardiac output, mean arterial pressure, and effective arterial elastance (HR x (1/NIVC) all
increased significantly. Non-ischemic vascular conductance approached significance
(p=0.053) between exercise and muscle metaboreflex activation. After induction of heart
failure, resting values of heart rate and effective arterial elastance were significantly
increased and, stroke volume, cardiac output, stroke work, mean arterial pressure and
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Figure 3.1 Average one-minute steady state hemodynamic values taken at rest (REST), exercise (3.2 km/h 0% grade)
(EX), and exercise with muscle metaboreflex activation (MMA) before (white) and after induction of heart failure via
rapid ventricular pacing (gray). Standard error of the mean is shown on the bar graphs. Statistical significance against
previous workload is shown as * P < 0.05. Comparisons between control and heart failure for a given workload shown
as † P < 0.05. (N=14).

hindlimb blood flow were significantly reduced and no difference was observed in nonischemic vascular conductance. From rest to exercise stroke volume, cardiac output,
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mean arterial pressure, non-ischemic vascular conductance and stroke work significantly
increased and all except non-ischemic vascular conductance were significantly
attenuated compared to control. Heart rate significantly increased from rest to exercise
but was significantly higher vs. control. In heart failure from exercise to muscle
metaboreflex activation all variables significantly increased. However, all variables were
significantly attenuated when compared to control with the exceptions of heart rate and
effective arterial elastance which were significantly increased. Hindlimb blood flow was
significantly reduced in heart failure at rest. Significant increases were observed in
hindlimb blood flow from rest to exercise however the steady state level during exercise
was significantly attenuated compared to control. Hindlimb blood flow was mechanically
reduced to comparable levels to elicit the muscle metaboreflex after induction of heart
failure.
Figure 3.2 shows the average steady-state values in 14 animals during rest,
exercise, and exercise with peak muscle metaboreflex activation before and after
induction of heart failure. In control experiments significant increases were observed in

Figure 3.2 Left average 1-minute steady state values of dP/dt MAX and MIN taken at rest (REST), exercise (3.2 km/h
0% grade) (EX), and exercise with muscle metaboreflex activation (MMA) before (white) and after induction of heart
failure via rapid ventricular pacing (gray). Right shows the average change from EX to MMA in control and heart
failure. Standard error of the mean is shown on the bar graphs. Statistical significance against previous workload is
shown as * P < 0.05. Comparisons between control and heart failure for a given workload or change from previous
workload shown as † P < 0.05. (N=14).
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dP/dt MAX from rest to exercise and from exercise to peak muscle metaboreflex activation.
dP/dt

MIN

was not significantly changed from rest to exercise but was significantly

increased from exercise to muscle metaboreflex activation. After induction of heart failure,
dP/dt

MAX

and

MIN

were significantly reduced at rest and increased between rest and

exercise and between exercise and muscle metaboreflex activation, however after
induction of heart failure these responses were all attenuated.
Figure 3.3 shows the relationship between dP/dt

MAX and MIN and

hindlimb blood

flow (left columns) and the slope (gain) of these relationships (right column) in 7 animals

Figure 3.3 Assessment of muscle metaboreflex gain as judged by the slope of the line from threshold to maximal
muscle metaboreflex activation before (solid circles, white bars) and after induction of heart failure via rapid ventricular
pacing (open circles, grey bars). Line graphs should be observed from the right point (exercise) to the middle point
(reflex threshold) to the final point left (peak muscle metaboreflex activation) as hindlimb blood flow is reduced.
Statistical significance between control and heart failure shown as † P < 0.05. (N=7).

before and after induction of heart failure (data analyzed as described previously,(40, 41,
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64, 93-96, 144, 145). The graphs on the left show the average values during steady-state
exercise (right-hand points), the average threshold of the reflex (middle points) and the
values observed at peak metaboreflex activation (left hand points) before and after
induction of heart failure. In heart failure, the baseline levels of hindlimb blood flow during
mild exercise were lower and ventricular contractility was decreased. There was no
change in the threshold level of hindlimb blood flow in heart failure and upon muscle
metaboreflex activation the slope of the relationships between hindlimb blood flow and
dP/dt MAX and MIN were significantly lower.
Figure 3.4 shows the contraction/relaxation rate ratios at rest, exercise and
metaboreflex activation (left) and the changes seen with metaboreflex activation (right) in
14 animals before and after induction of heart failure. In normal subjects, the

Figure 3.4 Average one-minute steady state values of the ratio of dP/dt MAX divided by dP/dt MIN taken at rest (REST),
exercise (3.2 km/h 0% grade) (EX), and exercise with muscle metaboreflex activation (EX + MMA) before (white) and
after induction of heart failure via rapid ventricular pacing (gray). Right shows the average change from EX to EX +
MMA in control and heart failure. Standard error of the mean is shown on the bar graphs. Statistical significance against
previous workload is shown as * P < 0.05. Comparisons between control and heart failure for a given workload or
change from previous workload shown as † P < 0.05. (N=14).

contraction/relaxation ratio at rest is greater than 1.0 and significantly increases from rest
to exercise which favors contraction. With muscle metaboreflex activation the ratio
significantly reduces back towards 1.0 indicating a larger improvement in the relaxation
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rate relative to the contraction rate during muscle metaboreflex activation. After induction
of heart failure, the ratio is significantly lower at rest, there is a small but statistically
significant increase from rest to exercise but no further significant changes in the ratio
occurred during muscle metaboreflex activation. Thus, in normal animals metaboreflex
activation results in a large reduction in the ratio whereas in heart failure there is little
change.
DISCUSSION
This is the first study to demonstrate that muscle metaboreflex activation enhances
ventricular relaxation rate relative to the contraction rate and that these increases are
stifled in heart failure. Additionally, we observed that ventricular contraction and relaxation
rates are maintained near a ratio of 1:1 in healthy and heart failure similar to what is
observed in genetic models of rats (85, 86) however in-vivo this ratio does vary with
exercise and metaboreflex activation. Significant differences in contraction-relaxation
ratios were observed in healthy subjects between rest, exercise and with muscle
metaboreflex activation. We observed that from rest to mild exercise there was a
significant increase in the ratio favoring contraction rate. However, with subsequent
muscle metaboreflex activation there was a reduction in the ratio to return closer to 1.0
implying significant greater increases in relaxation rate relative to contraction rate. This
improved relaxation rate would favor improved ventricular filling time and thereby may aid
in the ability to raise cardiac output. In heart failure the effect of metaboreflex activation
on the contraction-relaxation ratio was abolished. This failure to substantially improve
relaxation rate in heart failure may contribute to the impaired ability to raise cardiac output.
In addition to the effects observed regarding contraction/relaxation ratios, this is the first
study to quantify the gain of the muscle metaboreflex control of ventricular dP/dt MAX and
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MIN

and the effects of heart failure on metaboreflex gain of dP/dt MAX and MIN. We observed

that gain of the muscle metaboreflex control of both the ability to improve contraction and
relaxation are substantially impaired in heart failure.
Previously, we have observed that during metaboreflex activation in normal
subjects, the increased sympathetic activity to the heart limits coronary vasodilation due
to activation of vascular alpha-adrenergic receptors and that this functional
vasoconstriction restrains the ability to raise ventricular function (40). In heart failure, frank
coronary vasoconstriction occurs and further restrains already compromised ventricular
performance (13, 41). After blockade of alpha adrenergic receptors, this coronary
vasoconstriction is reversed to coronary vasodilation during metaboreflex activation and
coronary blood flow increases substantially and there are significant improvements in
ventricular function (40, 41). Furthermore, we have shown that ventricular-vascular
coupling is also markedly altered in heart failure as much greater increases in arterial
elastance occurs which are unaccompanied by increases in ventricular elastance thereby
further uncoupling an already impaired ventricular-vascular relationship (115). The higher
the arterial elastance the less effective energy transfer becomes and this in turn reduces
the ability to improve stroke work. Interestingly, even with reduced energy transfer and
poor vascular accommodation, muscle metaboreflex-induced central blood volume
mobilization in heart failure is sustained. (131). Thus, the inability to improve cardiac
output in heart failure is likely not only a result of reduced ventricular contraction (13, 41,
129, 144) but also poor relaxation dynamics that may be affected by changes in coronary
artery blood flow similar to contractile function as seen in our previous studies (13, 40,
41, 130, 166). In-depth analyses of diastolic function during exercise and metaboreflex
activation in heart failure are not well understood, however in the present study we have
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shown that relaxation rate is altered during muscle metaboreflex activation and this likely
significantly impacts diastolic performance.
IMPLICATIONS
The muscle metaboreflex is a negative feedback reflex which acts to lessen
metabolite accumulation in the skeletal muscle by increasing total systemic blood flow
(e.g. cardiac output) as well as arterial O2 content via red blood cell mobilization (40, 42,
45, 49, 76, 80, 127, 140, 145, 153). In healthy subjects during relative ischemia when the
levels of metabolites rise within the skeletal muscle, they activate metabosensitive
afferents. These afferents activate cardiovascular centers within the brain to increase
sympathetic outflow. This culminates in tachycardia and increased ventricular function
thereby raising cardiac output and

2

mediated vasodilation via epinephrine release.

Combined these enhance skeletal muscle blood flow and oxygen delivery which reduces
the interstitial metabolite concentration (13, 47, 49, 128, 150, 151, 153). Muscle
metaboreflex activation also enhances central blood volume mobilization thereby
maintaining ventricular filling pressure which thereby supports the enhanced ventricular
performance in order to sustain the reflex increase in cardiac output. In heart failure,
during exercise skeletal muscle blood flow is low and is already near, at, or beyond the
threshold required to elicit activation of skeletal muscle afferents depending on the
workload (64, 65). Muscle metaboreflex activation causes vasoconstriction in inactive
vascular beds and even within the active skeletal muscle - the vascular bed from which
the reflex originates thereby exaggerating the original response developing a limiting
positive feedback loop (94, 95). Although the muscle metaboreflex elicits tachycardia in
heart failure, ventricular function is compromised and exaggerated coronary
vasoconstriction (41) further limits reflex increases in cardiac output. Thus, the ability of
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the reflex to improve perfusion to the ischemic muscle is compromised. Although central
blood volume mobilization is sustained in heart failure (131), we observed in the present
study that ventricular relaxation rate is depressed at rest and during mild exercise and the
metaboreflex-induced reflex increases in relaxation rate are attenuated To what extent
these impairments in diastolic function are related to exaggerated metaboreflex-induced
coronary vasoconstriction are unknown.
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CHAPTER 4: CHRONIC ABLATION OF TRPV1 SENSITIVE SKELETAL MUSCLE
AFFERENTS ATTENUATES THE MUSCLE METABOREFLEX
ABSTRACT
Exercise intolerance is a hallmark feature seen in a variety of cardiovascular
pathologies. One of the mechanisms by which these symptoms likely occur is enhanced
activation of the muscle metaboreflex. The muscle metaboreflex vasoconstrictor
response occurs as a result of activation of metabolite-sensitive afferent fibers located in
ischemic active skeletal muscle some of which express the Transient Receptor Potential
Vanilloid 1 (TRPV1) cation channel. Local cardiac and intrathecal administration of an
ultra-potent noncompetitive, dominant negative agonist resiniferatoxin (RTX) can
attenuate cardiac sympathetic afferent activation and sensations of nociceptive pain by
ablating these TRPV1 sensitive afferents. This study investigated if intrathecal
administration (L4-L6) of RTX (2 g/kg) was capable of chronically attenuating the muscle
metaboreflex elicited by partial reductions in hindlimb blood flow during mild exercise (3.2
km/h) in chronically instrumented conscious canines. In this study we observed that
administration of intrathecal RTX significantly attenuated muscle metaboreflex induced
increases in mean arterial pressure (27
(1.40

0.2 L/min to 0.28

5.0 mmHg to 6

0.1 L/min) and stroke work (2.27

L*mmHg). These effects were maintained until 78

8.2 mmHg), cardiac output
0.2 L*mmHg to 1.01

0.2

10 days post RTX at which point the

efficacy of RTX injection was tested in a terminal experiment by intra-arterial
administration of capsaicin (20 g/kg). A significant reduction in mean arterial pressure
response (+45.7 6.5 mmHg pre RTX vs +19.7 3.1mmHg post RTX) was observed. We
conclude that intrathecal administration of RTX can chronically attenuate the muscle
metaboreflex and could potentially alleviate enhanced sympatho-activation observed in
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cardiovascular disease states such as heart failure and hypertension.
INTRODUCTION
Whole body dynamic exercise presents one of the greatest challenges to
cardiovascular control as heart rate and cardiac output rise from resting values to maximal
levels during peak workloads (19, 24, 38, 42, 43, 45, 49, 78, 93, 127, 128, 145, 151, 155).
Blood flow to inactive vascular beds is reduced in many species and vasodilation in the
active skeletal muscle and even the coronary circulations are restrained by the substantial
increases in sympathetic activity (40, 41, 94, 95). These marked changes in autonomic
activity occur through the action and likely interaction between activation of central
command, resetting of the arterial baroreflex, and activation of skeletal muscle afferents.
In cardiovascular dysfunction, these challenges often become exacerbated as systemic
perfusion and cardiac function may be compromised resulting in massive sympathetic
activation. One potential mechanism mediating the enhanced sympathetic activity during
exercise in cardiovascular disease is over-activation skeletal muscle afferents, in
particular those activated via accumulation of metabolites due to suboptimal oxygen
delivery – termed the muscle metaboreflex (1, 2, 47, 66, 70, 91, 92, 123, 135, 142, 150,
153, 158, 160-162). Even in normal subjects this reflex is thought to become tonically
active at relatively modest workloads and activation of this reflex can cause substantial
increases in sympathetic activity which elicits increases in cardiac output via tachycardia,
increased ventricular contractility and central blood volume mobilization (13, 43, 45, 49,
58, 59, 67, 93, 96, 127, 128, 131, 140, 145, 151, 154, 155). Arterial elastance rises in
parallel with ventricular maximal elastance thereby optimizing ventricular-vascular
coupling and energy transfer from the left ventricle to the systemic circulation (115, 144,
145). Peripheral vasoconstriction can also occur which is countered by adrenal
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mediated vasodilation (13, 94, 96, 140). Normally, these

responses act to correct about 50% of any blood flow deficit to the active muscle.
Splanchnic constriction mobilizing red blood cells increases arterial O2 content and O2
deficit is increased even further than blood flow as the reflex increase in blood flow now
contains more O2 (49, 153, 183) In pathophysiological states, even during moderate
workloads

this

reflex

becomes

markedly

over-activated

and

often

profound

vasoconstriction occurs in inactive vascular beds and even the ischemic active muscle
and heart are vasoconstricted (41, 44, 64, 95, 129, 154, 166, 167). This exacerbates an
already precarious situation leading to positive feedback amplification of sympathetic
activity (94, 95). The potentially extreme levels of sympathetic activity may pose
increased risks for adverse cardiovascular events such as stroke, myocardial infarction,
ventricular arrhythmia and sudden cardiac death. Thus, mechanisms to ameliorate overactivation of skeletal muscle afferents during exercise in patients with cardiovascular
disease may be beneficial.
Skeletal muscle metabo-sensitive afferents respond to a number of substances via
stimulation of a variety of receptors. These receptors include TRPV1 channels which are
non-selective cation channels known to be stimulated by a variety of stimuli such as
temperature, and H+ ion concentration (1, 48, 55, 61, 174). Recent studies have
investigated the impact of stimulating or antagonizing TRPV1 expressing afferents
utilizing capsaicin, capsaizapine, their analogs, and other various pharmaceutical
compounds (72, 74, 84, 124, 162, 165, 181, 186, 187). These studies found that activation
of TRPV1 receptors has been linked not only to initiation of blood pressure responses but
also the sensation of nociceptive pain (15, 26, 28, 84, 106, 108, 124, 146, 177). Short
term attenuation of type III and IV afferents including those expressing TRPV1, during
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exercise, decreases the sensation of muscle fatigue as well as the pressor responses
during exercise via activation of Mu opioid channels. (8, 20, 56). Whether these afferents
can be chronically ablated is unclear. In this study we hypothesized that chronic ablation
of TRPV1 expressing afferent neurons in the hindlimbs could be used to chronically
reduce the strength or gain of the muscle metaboreflex. In a longitudinally designed study,
we first established the strength of the muscle metaboreflex in chronically instrumented
canines during mild exercise. We then used an ultra-potent dominant negative agonist of
capsaicin, resiniferatoxin (RTX) injected into the intra-thecal space to partially destroy
afferents expressing TRPV1 afferents. We repeated the experiments from 7 to 78

10

days after injection and found that the strength of the muscle metaboreflex was
chronically attenuated by over 50%. We conclude that this approach could be useful to
attenuate exaggerated sympathetic activation during exercise in patients with
cardiovascular disease.
METHODS
Experimental subjects
Six adult mongrel canines (1 male, 5 female) of approximately 19-25 kg were
selected based on willingness to walk on a motor driven treadmill. We have previously
shown that sex does not affect the strength or mechanisms of muscle metaboreflex
activation (104). Canines were acclimatized to exercise at a workload of 3.2 km/hr with a
0% grade. All experimental and surgical procedures utilized for this study comply with the
National Institutes of Health Guide to the Care and Use of Laboratory Animals and were
approved by the Wayne State University Institutional Animal Care and Use Committee
(IACUC). Animals utilized in this study underwent a fourteen-day acclimation period with
the laboratory surroundings and personnel and exercised on their own volition during all
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experiments.
Surgical Instrumentation
All animals underwent a series of surgical procedures over a period of four weeks
using standard aseptic surgical techniques. Prior to each surgery, animals were sedated
with an intramuscular injection of acepromazine (0.4-0.5 mg/kg) and administered a sub
cutaneous injection of slow release analgesic buprenorphine SR (0.03 mg/kg) 30 minutes
prior to induction of anesthesia. Induction was achieved by intravenous administration of
ketamine (5 mg/kg) and diazepam (0.2-0.3 mg/kg). Anesthesia was maintained pre and
intra operatively with (1-3%) isoflurane gas. Additional preoperative analgesic included
intravenous administration of carprofen (4.4 mg/kg). Postoperatively acepromazine (0.20.3 mg/kg IV) and buprenorphine (0.01-0.03 mg/kg IM) were administered as needed.
Acute proactive antibiotic (cephalexin 30 mg/kg IV) was administered pre and post
operatively. Prophylactic antibiotic (cephalexin 30 mg/kg PO BID) were administered to
prevent microbial infection.
The first surgical procedure was a left thoracotomy through the left 3rd/4th
intercostal space to expose the heart. The pericardium was incised and parted for
placement of a telemetric pressure transducer tip (TA11 PA-D70, DSI) into the apex of
the left ventricle that was tunneled from the telemeter body tethered subcutaneously
caudal to the thoracotomy incision site. The upper section of pericardium was then
retracted dorsally to expose the aorta and pulmonary vein. A section of the aortic trunk
was used for placement of a blood flow transducer (20 PAU, Transonic Systems) for
measure of cardiac output. Unrelated to the investigations of this study, four stainless
steel pacing leads (0-FLexon, Ethicon) were attached to the right ventricle free wall. All
leads, and cables were tunneled subcutaneously and exteriorized between the scapulae.
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The pericardium and ribs were reapproximated and the chest was closed in layers.
The final surgical procedure occurred at a minimum of 14 days post thoracotomy.
A left retroperitoneal approach was used to access the terminal aorta. All arterial blood
vessels caudal to the renal artery and cranial to the edge of the incision above the iliac
crest were ligated. The most accessible cranial arterial branch caudal to the renal artery
was catheterized with a 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) for measure
of arterial pressure. In order, cranial to caudal, placed caudal to the arterial catheter, a
blood flow transducer (10 PAU, Transonic Systems) and two 8-10mm hydraulic occluders
(DocXS Biomedical Products) were placed to measure and manipulate hindlimb blood
flow. All cables and occluder lines were tunneled subcutaneously and exteriorized
between the scapulae.
Intrathecal RTX Administration and Terminal Capsaicin Response
Administration of RTX was performed after completion of all control experiments.
Prior to this procedure animals were sedated, induced, anesthetically maintained, and
treated with the same analgesics and aseptic techniques as described above in the
surgical procedures. Flow probes and pressure transducers were connected. Heart rate
and mean arterial pressure responses were taken during a one-minute steady-state prior
to administration of each pharmaceutical agent, as well as, peak responses post
administration for analysis. Prior to placement of the spinal needle, intra-arterial capsaicin
(20

g/kg) was administered through the catheter placed in the terminal aorta. After

recovery from capsaicin administration a 20-22-gauge spinal needle was placed into the
intrathecal space between the L4-L5 or L5-L6 vertebrae. Placement of the spinal needle
was done based on animal positioning, alignment, and successful observation of
cerebrospinal fluid through the needle. Spinal fluid equal to the volume amount of
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intrathecal RTX administered to reach the desired dose volume (2 g/kg) plus 0.5 ml to
use as a flush was removed. RTX was then administered through the spinal needle at a
concentration of 2 g/kg followed by flush of 0.5 ml spinal fluid and removal of the spinal
needle. After approximately 30 minutes and recovery from responses to RTX, a second
intra-arterial injection of capsaicin (20 g/kg) was performed. Animals were monitored
post operatively and administered acepromazine (0.2-0.3 mg/kg IV) and buprenorphine
(0.01-0.03 mg/kg IM) as needed. Metaboreflex experiments were repeated after a 7-10
day recovery period. After completion of all experiments a final terminal anesthetic
procedure was performed to assess the long-term efficacy of the RTX injection. Animals
were sedated, induced, treated with analgesics and anesthetically maintained as
described above in the surgical procedures. All equipment was connected as described
above and steady-state values of in vivo hemodynamics were taken during a one-minute
steady-state prior to intra-arterial administration of capsaicin (20 g/kg).
Data Acquisition
Animals were acclimated 10-20 minutes in the laboratory setting and then led to
the treadmill and equipment. Arterial pressure was measured by connection of the 19gauge polyvinyl catheter (Tygon, S54-HL, Norton to a pressure transducer (Transpac IV,
ICU Medical). Left ventricular pressure telemeter (DSI) and blood flow transducers were
connected to their appropriate instrumentation. All flows and pressures were monitored
and recorded in real time through an A-D converter (IWorx). A-D output was run through
Labscribe4 acquisition and analysis software (IWorx).
Experimental Procedures
All hemodynamic parameters were measured under steady-state conditions during
rest, mild free flow exercise (3.2 km/h 0% grade), and during sustained mild free flow
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exercise with successive reductions in hindlimb blood flow used to activate the muscle
metaboreflex. Hydraulic vascular occluders (DocXS) were used to achieve reductions in
hindlimb blood flow to approximately 30% of free flow conditions for both control and RTX
treated animals. Experiments were repeated after RTX thus each animal served as its
own control in this longitudinally designed study.
Analysis
All in vivo hemodynamic parameters were continuously recorded during each
experiment. One-minute averaged steady-state values were taken after a three-minute
acclimation period at rest, free flow exercise, and during steady-state at each reduction
of hindlimb blood flow (HLBF). Measures of mean arterial pressure, cardiac output, and
hindlimb blood flow were measured in vivo. Heart rate was derived from the cardiac output
waveform. All other hemodynamic parameters were mathematically derived from in vivo
measurements.
Statistical Analysis
Systat Software (Systat 13.0) was used for statistical analysis. Data are reported
as the mean

SE and statistical significance was determined by an

level of P < 0.05.

Data were analyzed using a Two-way ANOVA for repeated measures and when a
significant interaction was observed, individual means were compared using C Matrix
Test for Simple Effects. Direct observations on changes in muscle metaboreflex gain, and
comparison in changes observed during surgical procedures were assessed by a
Students Paired T-test.
RESULTS
Figure 4.1A shows the pressor responses to i.a. capsaicin (20 g/kg) before and
approximately 30 minutes post RTX injection. RTX markedly attenuated the pressor and

48
tachycardic responses to capsaicin. Figure 4.1B shows the responses to i.a. capsaicin
performed in a terminal procedure 78 ± 10 days after intrathecal administration of RTX.
Compared to the responses observed prior to RTX, the pressor and tachycardic
responses to capsaicin were significantly attenuated by ~ 50%.

Figure 4.1A Intraoperative responses to intra-arterial administration of capsaicin (20 g/kg) while under isoflurane
anesthesia. Pre RTX (Grey) and Post RTX (Red) are the delta responses comparing a one-minute steady-state prior
to capsaicin administration to the maximal response for each variable after administration. 4.1B intraoperative
responses to intra- arterial capsaicin (20 g/kg) prior too administration of RTX and during a terminal experiment
performed 78 14 days post injection of RTX. Bar graphs show standard error of the mean with individual data points
overlain. Standard error shown on bar graphs with actual data points overlain. Statistical significance is shown
compared to previous condition and shown as † (P < 0.05). (N=6)

Figure 4.2 shows that in control experiments heart rate (HR), stroke volume (SV)
cardiac output (CO) and stroke work (SW) increased significantly from rest to exercise
whereas there were no significant changes in mean arterial pressure (MAP) or effective
arterial elastance (EaZ, an index of vascular load (97, 115)) likely as a result of the
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significant increases in non-ischemic vascular conductance (NIVC, vascular conductance
to all vascular beds except the
hindlimbs calculated as (COHLBF) / MAP). During muscle
metaboreflex

activation

HR,

SV, CO, SW, EaZ and MAP all
increased significantly with no
significant increases in NIVC
when compared to the free flow
exercise condition. Intrathecal
RTX injection had no effect on
MAP, HR, SV, CO, NIVC SW,
or EaZ at rest and during steadystate exercise. However, after
RTX

muscle

responses

metaboreflex

were

virtually

abolished: only SW showed a
small but statistically significant
increases in response to similar
reductions in HLBF.

Figure 4.2 One-minute averaged hemodynamic responses taken during
steady-states at rest, exercise (3.2 km/h 0% grade) and during exercise with
muscle metaboreflex activation before (Grey) and after administration of
intrathecal RTX (2 g/kg) (L4-L6) (Red). Bar graphs show standard error of
the mean with individual data points overlain. Standard error shown on bar
graphs with actual data points overlain. Statistical significance is shown as *
(P < 0.05) compared to previous workload and significance to previous
condition and shown as † (P < 0.05). (N=6).

Figure 4.3 shows a comparison of changes observed in the hemodynamic values
between steady-state mild exercise (3.2 km/h 0% grade) and steady-state maximal
muscle metaboreflex activation. Increases in HR and SV were significantly attenuated
which thereby lowered CO after intrathecal administration of RTX. The significant
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reduction in the increase of MAP after intrathecal RTX is primarily a result of the lack of
CO response, the normal increases in SW and EaZ were also reduced.

Figure 4.3. Average change between one-minute steady-state values taken during exercise (3.2 km/h 0% grade) and
during exercise with muscle metaboreflex activation before (Grey) and after administration of intrathecal RTX (2 g/kg)
(L4-L6) (Red). Standard error shown on bar graps with actual data points overlain. Statistical significance shown as †
(P < 0.05) compare to previous condition. (N=6)

Figure 4.4 is a comparison of the reflex gain defined as the slope of the regression
line from the threshold of reflex to peak muscle metaboreflex activation of between MAP,
CO, and HR vs. hindlimb blood flow before and after RTX. The slopes of MAP, CO, and
HR were significantly attenuated after treatment with RTX. The slope of CO relationship
showed the largest reduction by approximately 70 percent compared to reductions of
MAP and HR of approximately 50%.
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Figure 4.4 Assessment of changes in the gain of the muscle metaboreflex determined by the slope of the linear
regression taken from one-minute averaged steady-states at each successive reduction in hindlimb blood flow from
threshold to peak reflex activation before (black circles, grey bars) and after administration of RTX (red circles, red
bars). Line graphs should be observed from the right point (exercise) to the middle point (reflex threshold) to the final
point left (peak muscle metaboreflex activation) as hindlimb blood flow is reduced. Standard error shown on bar graps
with actual data points overlain. Statistical significance between control (Grey) and after administration of intrathecal
RTX (2 g/kg) (L4-L6) (Red) shown as † (P < 0.05). (N=6)

DISCUSSION
This is the first study to demonstrate that chronic attenuation of muscle
metaboreflex activation can be achieved by ablation of TRPV1 sensitive afferents via
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intrathecal administration of RTX. We determined that intrathecal RTX attenuates the
muscle metaboreflex primarily through significant reductions in heart rate and stroke
volume and attenuation of ventricular performance indexed by stroke work. These
reduced responses lower the reflex increase in cardiac output. Inasmuch as in normal
subjects during submaximal dynamic exercise, the increase in cardiac output is the major
mechanism mediating the rise in arterial pressure, with the reduced rise in cardiac output
the metaboreflex pressor response was significantly attenuated.
Traditionally, the muscle metaboreflex increases cardiac output via the combined
effects of tachycardia, increased ventricular contractility, and enhanced central blood
volume mobilization (13, 127, 131, 145). This reflex arises due to activation of
metabosensitive skeletal muscle afferents (2, 91, 92, 135, 142, 156, 161).

These

afferents are primarily type IV but some type III afferents, which primarily respond to
mechanical stimulation, are also metabo-sensitive (91, 92, 162, 164, 165). These metabosensitive afferents respond to TRPV1 agonists (48, 84, 109, 162). In the present study
we utilized a non-competitive agonist to ablate TRPV1 sensitive afferent fibers in the
hindlimb skeletal muscle. Intrathecal RTX itself usually caused a pressor response likely
due to irreversible activation of the TRPV1 receptors. Thirty minutes to one hour later,
the reflex responses to i.a. capsaicin were significantly attenuated. Metaboreflex
experiments were performed 7-78

10 days after RTX and the responses were

consistently reduced. In the terminal experiment the responses to i.a. capsaicin were
reduced by approximately 50% indicating sustained significant ablation of afferents
containing TRPV1 receptors after 78

10 days. The lack of complete ablation is likely a

result of multiple factors such as toxin volume delivered, intrathecal flow, and the levels
of TRPV1 receptors available per neuron to accept RTX and achieve the level of cation
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flow required for cytotoxicity. Furthermore, expression patterns of TRPV1 neurons likely
vary per neuron and their upregulation and downregulation from various stimuli may play
a role in injection efficacy. Wang et al. showed that TRPV1 protein levels can vary based
on pathological state (179) possibly acting as a compensatory mechanism in response to
enhanced levels of metabolites in muscle with reduced blood supply.
Peripheral vascular responses were altered post RTX. We observed a significant
reduction in non-ischemic vascular resistance during muscle metaboreflex activation
likely as a result of reduced

2

mediated vasodilation observed in previous studies (94-

96). We have shown that muscle metaboreflex activation enhances ventricular maximal
elastance and effective arterial elastance such that ventricular-vascular coupling is
maintained and stroke work is optimal (115, 145). In this study intrathecal RTX
significantly attenuated increases in stroke work with no significant changes in effective
arterial elastance. Reductions in stroke work is probable evidence of some degree of
ventricular-vascular uncoupling, likely a result of reductions in ventricular maximal
elastance during muscle metaboreflex activation post RTX. In addition to overall
reductions in hemodynamic responses to graded reductions in hindlimb blood flow, we
also observed significant reductions in the gain of the muscle metaboreflex. Calculation
of muscle metaboreflex gain (strength) is quantified via the slope of the regression line
between a given hemodynamic parameter vs. the reduction in hindlimb blood flow once
beyond metaboreflex threshold. We observed that not only are maximum hemodynamic
values attenuated but also that the slope of mean arterial pressure, heart rate, and cardiac
output relationships vs. hindlimb blood flow are significantly reduced with no change in
threshold indicating that reflex gain is reduced for all observed hemodynamic parameters.
These experiments were performed only during mild exercise and to what extent
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metaboreflex responses after RTX are different at higher workloads remains to be
investigated.
IMPLICATIONS
Several cardiovascular diseases (e.g. heart failure, hypertension, peripheral
vascular disease) alter the strength and mechanisms of the muscle metaboreflex (13, 41,
64, 129, 144, 166, 167). Impaired ventricular function can occur not only from the direct
effect of the disease, but also from enhanced reflex coronary vasoconstriction (41, 166)
which thereby contributes to the attenuated ability to raise cardiac output and thus correct
metabolic mismatches in ischemic active skeletal muscle. Not only the heart, but also the
ischemic muscle becomes a target for metaboreflex – induced vasoconstriction (95).
Inability to improve perfusion of ischemic active skeletal muscle in heart failure causes
enhanced sympathetic activation due to over-activation of the muscle metaboreflex (41,
95). In heart failure ventricular-vascular interaction is already uncoupled and enhanced
sympathetic outflow further decouples this relationship which thereby lessens the ability
to sustain or improve skeletal muscle blood flow (115). Impaired ventricular function and
ventricular- vascular interactions leads to an enhanced vasoconstriction even within the
ischemic muscle (95). Limitations in raising skeletal muscle blood flow are thus both the
cause and effect of an enhanced metabolic mismatch that causes the enhanced
sympathetic activation in heart failure and likely other cardiovascular pathologies such as
hypertension (20, 30, 63, 166, 167) To date no study has assessed the effect of chronic
chemical ablation of skeletal muscle afferents in cardiovascular disease during exercise.
A common symptom of these pathologies is exercise intolerance and fatigue, such that
quality of life and the will to exercise are reduced. Studies have shown that exercise
training regimens are capable of improving and in some cases correcting abnormal
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cardiovascular responses during exercise (3, 12, 15, 52, 68, 81, 105, 137, 180).
Furthermore, multiple studies have shown that attenuation of skeletal muscle afferents by
way of activation of mu opioid receptors located on lower body afferents improves
cardiovascular responses during exercise and reduces fatigue (6-8, 20, 156). In the
present study we observed that a reduction of skeletal muscle afferents via intrathecal
RTX was capable of significantly attenuating muscle metaboreflex responses during
exercise. In addition, we observed animals treated with RTX were capable of maintaining
workload performance with greater reduction in hindlimb blood flow, therefore, RTX may
also lessen the sensation of fatigue during exercise as observed in previous studies
utilizing opioids (7-10, 20, 124, 136, 156, 169, 177). Thus, chronic ablation of skeletal
muscle afferents may allow greater exercise-induced increases in cardiovascular fitness,
less exercise intolerance and improved overall quality of life.
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CHAPTER 5: CONCLUSIONS
The major findings from these studies are:
1) The muscle metaboreflex increases effective arterial elastance and maintains
ventricular-vascular coupling to increase stroke work. In heart failure baseline levels of
effective arterial elastance are higher and the ventricular-vascular relationship is
uncoupled. Metaboreflex induced increases in effective elastance worsen the ventricularvascular relationship and limit stroke work likely contributing to the impaired ability to raise
cardiac output and therefore improve skeletal muscle perfusion.
2) The contraction and relaxation rate ratio in vivo favors contraction during
exercise and muscle metaboreflex activation elicits robust increases in relaxation to bring
the ratio towards 1:1. In heart failure the ventricular contraction-relaxation ratio again
favors contraction albeit significantly attenuated compared to control. During muscle
metaboreflex activation increases in relaxation rate are significantly stifled preventing any
reflex induced change in the ratio. Additionally, muscle metaboreflex control of contraction
and relaxation gain is attenuated. It is possible that the enhanced coronary
vasoconstriction previously shown to effect contraction also effects relaxation function in
heart failure.
3) Intrathecal RTX significantly attenuates muscle metaboreflex activation. We
observed that reflex increases in heart rate, cardiac output, mean arterial pressure, stroke
volume, stroke work, effective arterial elastance are all attenuated after administration of
RTX. Furthermore, it is likely that

2

mediated vasodilation is also inhibited based on the

attenuation of various hemodynamic parameters and significantly lower non-ischemic
vascular conductance observed after administration of RTX. Intrathecal administration
was shown to be effective in attenuating muscle metaboreflex responses for 78 10 days.
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FUTURE DIRECTIONS
Future directions of these studies could include investigation of interaction
between the metaboreflex and the arterial baroreflex in the control of ventricular-vascular
coupling, the role of coronary vasoconstriction in control of cardiac relaxation dynamics,
and whether chronic ablation of skeletal muscle afferents could lower the exaggerated
increases in sympathetic activity seen during exercise in heart failure. The arterial
baroreflex is known to modulate both parasympathetic and sympathetic function through
changes in heart rate, and sympathetic outflow to modulate arterial pressure.
Furthermore, this control has been observed to be exerted on muscle metaboreflex
activation of the vasculature (13, 98-100). To what extent the baroreflex is capable of
attenuating healthy muscle metaboreflex induced increases in effective arterial elastance
is unknown. Furthermore, baroreflex function is altered in heart failure (12, 25, 37, 60, 68,
73, 77-79, 83, 98, 132, 182) and to what extent this effects baroreceptor unloading or
muscle metaboreflex induced changes in effective arterial elastance and therefore
ventricular-vascular coupling is unknown. However, it is likely that the baroreflex a more
vascular associated reflex would have a greater impact before and likely enhanced effect
after heart failure on effective arterial elastance as a result of baroreceptor unloading.
In this study we observed muscle metaboreflex activation significantly enhances
relaxation rate, and that heart failure attenuates these responses likely through enhanced
coronary vasoconstriction. However, this study did not assess muscle metaboreflex
control of diastolic function in regard to how these alterations in relaxation impact filling,
or the end diastolic pressure volume relationship. It is likely that there is significant
impairment in diastolic dynamics and that this also contributes to the inability to raise
cardiac output in heart failure and other cardiovascular pathologies.
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Intrathecal resiniferatoxin administration achieved approximately a 50% inhibition
of muscle metaboreflex activation and shows promise as a potential therapy for
attenuating the profound vasoconstriction observed during reflex activation in heart failure
and other pathologies. In this study complete attenuation was not achieved and thus
evaluation of possible compensatory mechanisms such baroreflex activation, or
mechanosensitive afferents polymodality must be explored. Furthermore, TRPV1
receptors are not the only receptors located on metabosensitive afferents and thus there
may be competition for receptor availability on the cell surface limiting toxin efficacy.
Finally, within the data two distinct populations were observed after administration of RTX,
animals whose baseline blood pressure at rest was reduced and those whom increased.
Could this be an effect of baroreflex compensation due to the loss of some form of
feedback from skeletal muscle afferents even in the absence of reduced perfusion.
Furthermore, studies have shown that attenuation of skeletal muscle afferents do not
affect baroreflex activity (60, 75), but those studies did not involve acute or chronic
ablation and thus more studies are warranted.
Other future directions include the evaluation of all of these studies within various
cardiovascular pathologies such as peripheral artery disease, hypertension, diabetes,
and metabolic syndrome. Additionally, in regard to metaboreflex mechanisms that
potentiate reflex activation, no study has assessed the impact of muscle metaboreflex
activation on energy availability in the muscle I.E. the ability to enhance glucose efflux
into active muscle, or the impact of metaboreflex sympathetic activity on pancreatic or
immunological function.
In summary, these studies unveiled multiple aspects of the muscle metaboreflex
that warrant further study in addition to adding more knowledge to the understanding of
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the reflex arc as a whole.
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Muscle Metaboreflex Activation occurs as a result of metabolic accumulation within
active skeletal muscle that stimulates type III and IV afferents. This reflex in healthy
subjects causes increased ventricular contraction, tachycardia, enhanced central blood
volume mobilization, and

2

mediated vasodilation as a means to increase mean arterial

pressure and thereby improve perfusion pressure of active skeletal muscle. However, to
date no study has evaluated the interaction between the observed changes in ventricular
and vascular dynamics or how the reflex impacts contraction relaxation dynamics before
and after induction of heart failure Furthermore, no study has evaluated the impact of
chronic selective ablation of skeletal muscle afferents responsible for reflex activation. In
this study we addressed three questions: 1) Does muscle metaboreflex activation
increase effective arterial elastance and maintain ventricular vascular coupling before and
after induction of heart failure, 2) Are ventricular contraction and relaxation dynamics
influenced by muscle metaboreflex activation and what is the effect of heart failure, 3)
What is the contribution of TRPV1 expressing skeletal muscle afferents to muscle
metaboreflex activation. We used a chronically instrumented canine model in a

89
longitudinally designed study in which each animal serves as its own control against either
induction of heart failure or treatment with intrathecal resiniferatoxin a potent dominant
negative TRPV1 agonist that causes afferent ablation to assess these questions. We
observed that: 1) Muscle metaboreflex activation does increase effective arterial
elastance and this increase sustains ventricular vascular coupling promoting optimal
energy transfer from the left ventricle to the systemic circulation and thereby increasing
stroke work. In heart failure baseline levels of elastance are increased and the ventricular
vascular relationship is uncoupled. Metaboreflex activation only worsens this relationship
by further increasing effective arterial elastance with little to no improvements in
ventricular maximal elastance. 2) The ventricular contraction and relaxation ratio is
sensitive to muscle metaboreflex activation and is primarily affected by large reflex
induced increases in relaxation rate. In heart failure metaboreflex activation does not alter
the ratio from exercise conditions and this is due to a significant attenuation in the ability
to increase relaxation rate. 3) TRPV1 sensitive skeletal muscle afferents account for 5070% of metaboreflex induced changes in cardiovascular performance. Maximal
hemodynamic responses to muscle metaboreflex activation are significantly attenuated.
Based on these effects intrathecal administration of resiniferatoxin poses as a potential
therapy to attenuate over sympatho-activaton during muscle metaboreflex activation in
heart failure.
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